European Patent EP4516265A1 for Transcatheter Aortic Valve Replacement
Summary
The European Patent Office has published patent EP4516265A1 for a transcatheter aortic valve replacement apparatus with a bilateral locking function, filed by Wuhan Weike Medical Technology Co. Ltd. This patent publication relates to advancements in medical technology for cardiovascular procedures.
What changed
European patent EP4516265A1, titled 'TRANSCATHETER AORTIC VALVE REPLACEMENT APPARATUS HAVING BILATERAL LOCKING FUNCTION', was published on March 11, 2026. The patent application was filed by Wuhan Weike Medical Technology Co. Ltd and lists several inventors. The publication details a specific apparatus for aortic valve replacement, indicating a new development in medical device technology.
This patent publication does not impose any new regulatory obligations or compliance deadlines on regulated entities. It serves as an informational notice regarding intellectual property granted in the field of medical devices. Compliance officers should note this as a development in the landscape of medical technology, particularly for companies involved in cardiovascular devices and prosthetics.
Source document (simplified)
TRANSCATHETER AORTIC VALVE REPLACEMENT APPARATUS HAVING BILATERAL LOCKING FUNCTION
Publication EP4516265A1 Kind: A1 Mar 11, 2026
Applicants
Wuhan Weike Medical Technology Co. Ltd
Inventors
CHEN, Song, WANG, Xueli, ZHANG, Changdong, SUN, Ming, WU, Chunlin
IPC Classifications
A61F 2/24 20060101AFI20250707BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.